middle.news

Boston Scientific sets financing for Penumbra acquisition

8:06am on Saturday 21st of November, 2026 AEDT • Healthcare
Read Story

Boston Scientific sets financing for Penumbra acquisition

8:06am on Saturday 21st of November, 2026 AEDT
Key Points
  • US$3 billion across four senior note tranches
  • €4.25 billion across six euro-denominated tranches
  • Proceeds earmarked primarily for the Penumbra acquisition
  • Euro notes fully and unconditionally guaranteed by Boston Scientific
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Boston Scientific (NYSE:BSX)
OPEN ARTICLE